Cardiovascular diseases (CVD) are the most common causes of patient
hospitalization and mortality in many developed nations. It continues
to be the leading cause of death worldwide as well. It is imperative
for a physician to perform cardiovascular imaging test to diagnose
heart condition and during subsequent management of any cardiac
disorder. Cardiovascular imaging (CV imaging) enables radiologist to
see inside the body and shows the structure of heart in great detail.
The physician can understand blood flow within the body and diagnose
patient’s heart or vascular condition. The global market for
cardiovascular imaging is expected to grow in the near future owing
to the increasing demand from the emerging economies in the
Asia-Pacific and rest of the world. Moreover, the increasing
dependence on imaging modalities have increased the adoption of
imaging informatics which is expected to witness far-reaching
positive impact on the global CV imaging and informatics market.
Report Overview @
https://www.transparencymarketresearch.com/cardiovascular-imaging-informatics-market.html
Echocardiography, angiography, nuclear cardiac imaging, computed
tomography, cardiac positron emission tomography (cardiac PET), and
cardiac magnetic resonance imaging (cardiac MRI) are the most common
imaging modalities used for diagnosis and interventional cardiology.
Other tests used for cardiovascular imaging include coronary calcium
score and coronary catheterization (catheter angiography). Coronary
catheterization is a minimally invasive procedure to access coronary
circulation by inserting a catheter into heart through blood vessels
in the leg. Cardiac CT is a less invasive option to coronary
catheterization which involves injecting CT-visible dye. Cardiac CT
offers advantage of minimizing the risk of arterial perforation and
reduces the chances of infection at catheter injection site. In the
late 1970s, CT scans required 2.4-sec for capturing an image, but the
development in the electron beam technology has significantly reduced
the time per scan. In addition, the development of multi-detector
scanners, it has become possible to obtain 64, 128, 256 and more
simultaneous slices adding more spatial resolution and diagnostic
help to radiologists.
Echocardiography imaging is an optional ultrasound method of cardiac
imaging and includes transthoracic echocardiography (TTE),
transesophageal echocardiography (TEE), stress echocardiography.
Recently, 3D echocardiography is being used for cardiovascular
imaging which is non-invasive, easy to operate, and produces much
clearer image. Nuclear cardiac imaging is becoming a popular method
which involves usage of a radionuclide - technetium Tc 99m sestamibi
(MIBI).
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9043
This non-invasive cardiac imaging method is considered to be one of
the best methods to evaluate and diagnose a heart attack. It is also
a very handy technique to assess myocardial salvage among patients
with acute myocardial infarction (MI). The market for non-invasive
cardiovascular imaging is expected to grow rapidly in the coming
years as the invasive imaging causes great inconvenience to the
patients. Moreover, the non-invasive imaging is less costly and
incurs comparatively lesser hospitalization to the patient.
Geographically, the global cardiovascular imaging and informatics
market can be segmented into four major regions, North America,
Europe, Asia-Pacific and Rest of the world. Geographically, the
Asia-Pacific market will witness highest growth in terms of
procedures and will outnumber the total imaging procedures in the
western part of the world. Large patient pool, increasing healthcare
infrastructure and strengthening economy in the region are
contributing to the growth of Asia-Pacific cardiovascular imaging and
informatics market.
Some of the key companies operating in the cardiac imaging and
informatics include GE Healthcare, Siemens Healthcare, Philips
Healthcare, Medis Medical Imaging Systems BV, Pie Medical Imaging,
and Circle Cardiovascular Imaging, Inc.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=9043<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment